All Articles

Barings' high-yield fund signals confidence with a steady dividend. What does this reveal about the debt market for capital-intensive mining projects?

The U.S. State Department is deploying a self-learning AI to protect its global diplomatic corps, signaling a new era in federal cybersecurity.

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

As AI-native fintech Henon plants its flag in London, its push for 'zero-error' finance signals a new competitive era for private capital in EMEA.

A century-old brand just launched a giant, novelty product. It’s not a joke—it’s a calculated lesson in modern marketing and brand revitalization.

A new report shows a startling drop in dental benefits, revealing deep cracks in America's health system and new economic pressures on employers.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

An award for recycling innovation signals a major market shift, as Aurora Material Solutions turns waste PVC into a high-value industrial asset.

A new platform lets your idle devices earn Bitcoin. Is this a futuristic lifestyle trend for luxury living or just a volatile digital experiment?

Beyond bureaucracy, a federal push for bilingual services aims to dismantle linguistic barriers, impacting health equity for minority communities across Canada.

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

Exodus is using its Bitcoin treasury to buy a payments firm, but declining user metrics and a change in disclosure raise questions about this bold strategy.

With its new CRO from Asana and LinkedIn, HR tech unicorn Lattice is betting on a human-centric AI strategy to dominate the future of performance management.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

The fight for STAAR Surgical heats up. Alcon's new $1.6B offer isn't enough for its largest shareholder, who alleges a deeply conflicted sales process.

A logistics firm's stock soared 1,100% then collapsed overnight. Inside the alleged pump-and-dump scheme that reveals deep cracks in market integrity.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Rivals like OpenAI, Google, and Microsoft are joining forces under the Linux Foundation to build open standards for autonomous AI. What does this mean?